Beigene, Ltd.
Patents = 52
Trademarks = 20
Forward Citations = 649
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
48 inventors (with patents filed for the assignee):
BeiGene, Ltd. is a commercial-stage biotechnology company that focuses on developing and commercializing innovative medicines for cancer treatment. With a global presence, BeiGene combines cutting-edge science and technology to discover, develop, and deliver globally accessible oncology drugs. The company is committed to improving treatment outcomes and patient lives through its pipeline of targeted and immuno-oncology therapeutics.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com